title: Lipoprotein(a) concentration and phenotypes in primary biliary cirrhosis.
abstract: We studied a selected group of 39 female patients suffering from primary biliary cirrhosis (PBC). This disease is characterized by typical lipoprotein alterations and elevated concentrations of serum cholesterol. Despite the increased concentration of atherogenic lipoproteins, enhanced atherogenesis is not characteristic of PBC. Serum total cholesterol, triglycerides, HDL2 and HDL3-cholesterol concentrations were measured by enzymatic methods or in combination with precipitation procedures. Apolipoproteins were determined by using immunonephelometric methods. ELISA sandwich method was used for lipoprotein(a) determinations. Apoprotein(a) phenotyping (isoforms) was performed by Western blotting with specific antibodies. The concentrations of serum lipids, lipoproteins and apoproteins (AI, AII and B) were found in the range of earlier investigations. The serum lipoprotein(a) concentration did not differ between the PBC patients and control subjects (10.0/0.1-54/, median 2.55 vs. 11.5/0-75/, median 5.2 mg/dl). In the advanced stages of PBC we found a higher number of patients with low lipoprotein concentration (lower than 1 mg/dl). In patients with shorter durations and milder histological alterations high HDL2 cholesterol subfractions has been detected (stage I = 0.42 +/- 0.18, stage II = 0.53 +/- 0.29 and stage III = 0.62 +/- 0.41 vs. stage IV = 0.26 +/- 0.15 mmol/l, P < 0.05). Despite the elevation of atherogenic lipoproteins, high HDL2-cholesterol and normal lipoprotein(a) concentrations may be one of the reasons why patients with advanced PBC are not placed at increased risk for atherosclerosis.
authors.affiliation: 3rd Department of Internal Medicine, Semmelweis Medical University, Budapest, Hungary.
authors.forename: L
authors.initials: L
authors.lastname: Romics
authors.forename: E
authors.initials: E
authors.lastname: Nemesánszky
authors.forename: F
authors.initials: F
authors.lastname: Szalay
authors.forename: A
authors.initials: A
authors.lastname: Császár
authors.forename: J
authors.initials: J
authors.lastname: Tresch
authors.forename: I
authors.initials: I
authors.lastname: Karádi
mesh_terms: D000328:Adult; D000368:Aged; D001161:Arteriosclerosis / Q000378:metabolism; D002784:Cholesterol / Q000378:metabolism; D005260:Female; D006801:Humans; D017270:Lipoprotein(a) / Q000097:blood* / Q000235:genetics*; D008075:Lipoproteins, HDL / Q000097:blood / Q000737:chemistry; D008105:Liver Cirrhosis, Biliary / Q000378:metabolism*; D008875:Middle Aged; D010641:Phenotype; D014580:Ursodeoxycholic Acid / Q000494:pharmacology
chemical_list: D017270:Lipoprotein(a); D008075:Lipoproteins, HDL; D014580:Ursodeoxycholic Acid; D002784:Cholesterol